Trial · NCT07909720
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in cycloplegic spherical equivalent refraction (SER) | Baseline, 4 months, 8 months, 12 months | SER will be measured using an autorefractometer after eye drops are given to temporarily relax the eye's focusing muscles. SER, measured in diopters (D), represents the amount of nearsightedness and will be used to measure the change in myopia from baseline. |
| Primary | Change in axial length (AL) | Baseline, 4 months, 8 months, 12 months | AL will be measured using the IOLMaster and reported in millimeters (mm). Change in AL from baseline will be used to assess ocular growth/myopia progression. |
| Secondary | Change in rate of SER increase | Baseline, 4 months, 8 months, 12 months | |
| Secondary | Change in rate of AL increase | Baseline, 4 months, 8 months, 12 months | |
| Secondary | Best corrected visual acuity (BCVA) | Baseline, 4 months, 8 months, 12 months | |
| Secondary | Change in National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) composite score | Baseline, 4 months, 8 months, 12 months | The NEI VFQ-25 is a 25-item questionnaire assessing vision-related functioning and quality of life. The composite score ranges from 0 to 100, with higher scores indicating better visual functioning and vision-related quality of life. |
| Secondary | Change in anterior chamber depth (ACD) | Baseline, 4 months, 8 months, 12 months | |
| Secondary | Change in corneal curvature (CC) | Baseline, 4 months, 8 months, 12 months | |
| Secondary | Change in choroidal thickness (CT) | Baseline, 4 months, 8 months, 12 months | |
| Secondary | Change in White-to-White (WTW) | Baseline, 4 months, 8 months, 12 months | |
| Secondary | Change in choroidal structures | Baseline, 4 months, 8 months, 12 months | |
| Secondary | Intraocular pressure (IOP) | Baseline, 4 months, 8 months, 12 months | |
| Secondary | Ocular and systemic symptoms | Baseline, 4 months, 8 months, 12 months | |
| Secondary | Ocular signs assessed by slit-lamp biomicroscopy and binocular indirect ophthalmoscopy | Baseline, 4 months, 8 months, 12 months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07909720/registered